pointed out that sputum IL-1β and serum IL-6 were higher in the frequent exacerbators with COPD, which activated the IL-1β-system inflammation axis to increase the risk of frequent exacerbations of COPD patients (Fu et al., 2015). This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.